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httpcense.Abstract Background: Both hepatopulmonary syndrome and portopulmonary hypertension are
associated with chronic liver disease. Liver transplantation is considered a controversial solution.
Aim: The aim of this work is to assess pulmonary hypertension in liver disease patients pre and
post liver transplantation. Studying the impact of pulmonary hypertension on hemodynamic of the
patients in hospital after liver transplantation.
Patients and methods: Echo cardiographic examination pre and post liver transplantation after
at least 3 months was conducted on 20 patients with chronic liver diseases and pulmonary
hypertension who underwent liver transplantation to estimate mean PAP and degree of tricuspid
regurgitation.
Results: The present study was conducted on 20 patients consisting of 18 males (90%) and two
females (10%) with mean age 47.8 ± 8.9. It showed that mean pulmonary arterial pressure
improved after liver transplantation 24.65%± 17.50.The tricuspid regurgitation before operation
was mild in 17 patients (85%) and moderate in three patients (15%) and after operation it become
normal in 40% and mild in 60% with improvement in 55% and no improvement in 45% of the
patients. There was improvement in dyspnea scale after the operation with one grade change in
35%, two grade change in 55% and three grade change in 10% of patients.yndrome; PPHTN, portopul-
bstructive pulmonary disease;
World Health Organization;
P, pulmonary artery pressure;
1130465.
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214 Y. Mustafa et al.Conclusion: Liver transplantation was effective in the reduction of pulmonary artery pressure.
The degree of pulmonary hypertension affected the functional state according to WHO Classiﬁca-
tion of pulmonary hypertension patients.
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Patients with chronic liver disease may show two pulmonary
vascular disorders that are considered mutually exclusive: on
the one hand, hepatopulmonary syndrome (HPS), which is
characterized by pulmonary vascular dilatations and abnormal
gas exchange [1], and on the other, portopulmonary hyperten-
sion (PPHTN), a process deﬁned by pulmonary hypertension
associated with portal hypertension [2].
If severe, both conditions are associated with a high mortal-
ity rate. The role of liver transplantation in reversing these
vascular disorders is controversial, although complete resolu-
tion of HPS and, less frequently, PPHTN, following liver
transplantation has been reported [3].
The reported frequency of hepatopulmonary syndrome in
patients with liver disease is between 4% and 29%. The differ-
ing incidence is primarily due to heterogeneity of the applied
diagnostic criteria. This syndrome is a well deﬁned cause of
hypoxemia in patients who have liver disease due to abnormal
intrapulmonary vascular dilatation, which results in an excess
perfusion for a given state of ventilation. This complication is
characterized by anatomical shunting and a diffusion–
perfusion abnormality [4].
Thus, abnormal pulmonary vascular dilatation plays a cen-
tral part in the hepatopulmonary syndrome, whereas abnormal
vasoconstriction and obliterative vascular remodeling are the
key features of portopulmonary hypertension [5].
Aim of the work
Assessment of pulmonary hypertension in liver disease patients
pre and post liver transplantation. Studying the impact of pul-
monary hypertension on hemodynamic of the patients in hos-
pital after liver transplantation.
Patients and methods
The present study was conducted on 20 patients with chronic
liver diseases and pulmonary hypertension who underwent li-
ver transplantation in the Ain Shams University Specialized
Hospital and Wadi Elnil Hospital.
All patients were subjected to the following:
(1) Full medical history.
(2) Thorough clinical examination.
(3) Chest X-ray postroanterior view.
(4) ECG before operation.
(5) Echo cardiographic examination pre and post liver
transplantation after at least three months to estimate
mean PAP and degree of tricuspid regurgitation.
(6) Pulmonary function test pre liver transplantation.(7) Pelvic-abdominal ultrasound pre liver transplantation to
assess portal hypertension.
(8) Recording of those patients who needed hemodynamic
support post operative.
We used the American Thoracic Society shortness of breath
Scale and World Health Organization functional assessment
classiﬁcation in our study [6].
Inclusion criteria
(1) Chronic liver disease with or without portal hyper-
tension.
(2) Estimated mean pulmonary artery pressure >25 mmHg.
(3) Survived patients after liver transplantation.
Exclusion criteria
– Chronic chest disease e.g. COPD and ILD.
– Cardiac disease e.g. valvular heart disease or congenital
heart disease.
– History of pulmonary embolism.
– Connective tissue disease.
The collected data were revised, coded, tabulated and sta-
tistically analyzed using SPSS 15 version.Results
The present study was conducted on 20 patients consisting of
18 males (90%) and two females (10%) with mean age
47.8 ± 8.9 having chronic liver disease and pulmonary hyper-
tension who underwent liver transplantation in the Ain Shams
University Specialized Hospital and Wadi Elnil Hospital.
Table 1 shows that mean pulmonary arterial pressure im-
proved after liver transplantation (Fig. 1).
Table 2 shows that tricuspid regurgitation before operation
was mild in 17 patients (85%) and moderate in three patients
(15%) and after operation it become normal in 40% and mild
in 60% with improvement in 55% and no improvement in
45% of the patients (Fig. 2).
Table 3 shows that there was improvement in post oper-
ative functional state as regards the WHO Classiﬁcation
with one class change in 35% of cases, two class change
in 35%, three class change in 25% and no change in 5%
of patients.
Table 4 shows that there was improvement in dyspnea scale
after the operation with one grade change in 35%, two grade
change in 55% and three grade change in 10% of patients
(Fig. 3).
Table 5 shows a highly signiﬁcant statistical difference be-
tween mean pulmonary arterial pressure, tricuspid regurgita-
Table 1 Description of mean pulmonary arterial pressure before and after operation and the resulting change due to operation among
the studied patients.
Mean ±SD Minimum Maximum
Mean pulmonary arterial pressure before transplantation 37.35 4.21 32.00 49.00
Mean pulmonary arterial pressure after 3 months at least 27.95 6.67 12.00 35.00
Mean pulmonary arterial pressure change 9.40 7.34 2.00 33.00
Mean pulmonary arterial pressure percent of change 24.65 17.50 6.25 73.33
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Figure 1 Description of mean pulmonary arterial pressure
before and after operation and the resulting change due to
operation among study patients.
Table 2 Description of tricuspid regurgitation before and
after operation and the resulting change due to operation
among study patients.
Number of patients %
TR before transplantation
Mild 17 85.0
Moderate 3 15.0
TR after at least 3 months
Normal 8 40.0
Mild 12 60.0
Change in TR
No improvement 9 45.0
Improvement 11 55.0
45%
55%
No improvement in TR Improvement in TR
Figure 2 Improvement in TR after operation
Table 3 Description of functional state according to WHO
classiﬁcation before and after operation and the resulting
change due to operation among study patients.
No. %
WHO classiﬁcation before
Class 1 0 .0
Class 2 6 30.0
Class 3 9 45.0
Class 4 5 25.0
WHO classiﬁcation after 3 months
Class 1 17 85.0
Class 2 3 15.0
Class 3 0 .0
Class 4 0 .0
WHO change in classiﬁcation
No change 1 5.0
One class change 7 35.0
Two class change 7 35.0
Three class change 5 25.0
Table 4 Description of degree of dyspnea scale (American
Thoracic Society) before and after operation and the resulting
change due to operation among study patients.
No. %
Dyspnea scale before
Moderate 3 15.0
Severe 15 75.0
Very severe 2 10.0
Dyspnea scale after 3 months of operation
None 3 15.0
Mild 11 55.0
Moderate 5 25.0
Severe 1 5.0
Very severe 0 .0
Dyspnea scale change
No change 0 .0
One Grade change 7 35.0
Two Grade change 11 55.0
Three Grade change 2 10.0
Assessment of pulmonary hypertension in patients with liver disease 215tion, functional classiﬁcation of pulmonary hypertension and
dyspnea scale before and after liver transplantation.There were four patients (20% of patients) who showed
post operative hemodynamic instability necessitating inotro-
pic/vasopressor support.
There was no signiﬁcant relation between the presence or
absence of pre-operative portal hypertension and the pre-
operative mean pulmonary hypertension or the need of post
operative hemodynamic support.
Percent
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Figure 3 Description – according to WHO classiﬁcation – of the
resulting change due to operation among study patients.
216 Y. Mustafa et al.Discussion
This is a preliminary study on the impact of liver transplanta-
tion on PAP, as liver transplantation surgery was recently used
in Egypt, so there were lack of statistical data to compare with.
In the present study, the estimated mean PAP was
37.35 ± 4.21 mmHg preoperatively which decreased to
27.95 ± 6.67 mmHg in the postoperative follow up for
3 months with the pressure percentage of change being
24.65 ± 17.50%.
These results matched with the study by Martınez Palli
et al. [7] who found that seven of 33 PPHTN patients undergo-
ing liver transplantation in their series (3 with MPAP
>45 mmHg) showed dramatically improved pulmonary pres-
sures at 18 months.
These results also matched the study by Bozbas et al. [8]
who studied 114 adult liver transplantation patients, 24
(21.1%) of them had PPHTN on Doppler echocardiography
examination. The results showed that the mean systolic PAP
was 46.6 ± 7.6 mmHg preoperatively which decreased to
37.8 ± 15.5 mmHg in the postoperative follow up.
Our result also matched a case report of a 38 years old male
patient who had liver cirrhosis and hepatitis c virus (Schott
et al. [9]) and his mean pulmonary artery pressure was
45 mmHg that decreased to 30 mmHg after one year of liver
transplantation.
On the other hand the current results contradict with two
case reports by Martinez-Palli et al. [10] who documented on
the increase in preexisting pulmonary hypertension after liver
transplantation and Albert et al. [11] who studied a 32 yearsTable 5 Statistical comparison between different indicators before
Mean
Mean pulmonary arterial pressure before 37.35
Mean pulmonary arterial pressure after 27.95
TR before 1.15
TR after .60
WHO classiﬁcation before 2.95
WHO classiﬁcation after 1.15
Dyspnea scale before 3.05
Dyspnea scale after 1.20
* Paired t test.old female patient who underwent liver transplantation at
the Cleveland Clinic Foundation with increase of PPHTN
after 4 years but it was only in one patient.
In the present study there were nine mild cases (45%), nine
moderate (45%) cases and two severe cases (10%) of pulmon-
ary hypertension according to the estimated mean pulmonary
artery pressure (Marius et al. [12]).
Our results agree with the results of a study by Saner et al.
(2006) among 74 consecutive patients that underwent LT be-
tween February 2004 and November 2005. The total incidence
of PPHTN was 31% and most of them had mild to moderate
PHTN (16 mild = 69.5%, 5 moderate = 21.7%, and 2 se-
vere = 8.8%). Also, Strakel et al. [13] found that most of the
patients of PHTN among liver transplant patients were mild
PHTN 31 of 38 patients (81.5%).
In the present study, there was an improvement in severity
of tricuspid regurgitation after liver transplantation. These re-
sults matched a case report done by Roland Schott et al. [9]
who found that the tricuspid regurgitation completely disap-
peared after 2 years of liver transplantation.
On the other side these results did not match with Albert
et al. [11] who found an increase in the severity of tricuspid
regurgitation after 4 years of liver transplantation but that
was a case report of one patient and after a long period of
operation in contrast to our study which was on 20 patients
and after 3 months to 1 year after operation.
In the present study the post-operative functional state
according to the WHO Classiﬁcation improved by one class
in 35% of patients, two classes in 35% of patients, and three
classes in 25% of patients while no improvement in 5% of
patients.
These results agreed with a case report by Roland Schott
et al. [9], however, this case report used The New York Heart
Association Classiﬁcation instead of WHO Classiﬁcation,
which revealed improvement of dyspnea from grade III to
grade I.
However, these results did not agree with a case report
Albert et al. [11] that revealed deterioration of dyspnea from
grade I to grade III–IV after liver transplantation as mean pul-
monary artery pressure was 45 and did not improve.
In the present study, there was an improvement in dyspnea
scale according to the American Thoracic Society after the
operation with one grade improvement in 35% of patients,
two grades improvement in 55% of patients and three grades
improvement in 10%.
These results agreed with the case report by Roland Schott
et al., (1998) [9] who found improvement of dyspnea from
grade III to grade I.and after operation.
±SD P* Sig.
4.209 .0001 HS
6.669
.366 .0001 HS
.503
.759 .0001 HS
.366
.686 .0001 HS
.768
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sure of 44.50 ± 3.42 mmHg and developed hemodynamic
instability after the operation.
These results agreed with the study by Le Pavec et al. [14] of
the French National Center for PAH between 1984 and 2004
and revealed that mean pulmonary artery pressure greater
than 35 mmHg and/or PVR greater than 250 dyn/s/cm5 have
an increased risk of hemodynamic instability and cardiopul-
monary death after liver transplantation.
These results were in concordance with a study by Krowka
et al. (2000) [15] who found that mean PAP greater than
35 mmHg is associated with an increased post-operative liver
transplantation mortality.
Also these results matched a database published by Kro-
wka et al. [16] from 10 liver transplant centers from 1996 to
2001, 13 (36%) of 36 patients who underwent liver transplan-
tation developed hemodynamic instability and died in the
hospital.
In the present study there was no difference in hospital stay
between patients who needed post operative hemodynamic
support (higher pulmonary hypertension) and who did not.
This result agreed with Strakel et al. [13] who found that the
duration of ventilation and intensive care unit stay was unaf-
fected by the degree of PPHTN.
But these results did not match the study by Bozbas et al.
[17] who found a longer length of post operative hospitaliza-
tion among patients with PHTN compared to those without
preoperative PHTN.
In our study there was nonstatistical difference in pulmon-
ary artery pressure between those patients who had portal
hypertension and those who did not.
Robalino and Moodie [18] studied the clinical, laboratory
and hemodynamic proﬁle of patients with primary pulmonary
hypertension and associated portal hypertension, seven new
cases and 71 previously reported cases were analyzed. Liver
cirrhosis was the most frequent cause of hypertension (82%)
and a surgical portosystemic shunt was present in 29%. Al-
most invariably, portal hypertension either preceded or was
diagnosed concurrently with pulmonary hypertension, favor-
ing the hypothesis that in portal hypertension, the pulmonary
vasculature may be exposed to vasoactive substances normally
metabolized or produced by the diseased liver, possibly induc-
ing vasoconstriction or direct toxic damage to the pulmonary
arteries. Clinically, exertional dyspnea was the most frequent
presenting symptom (81%); other symptoms, such as syncope,
chest pain and fatigue, were present in less than 33%. An
accentuated pulmonary component of the second heart sound
(82%) and a systolic murmur (69%) were the most common
physical ﬁndings. At least 75% of these patients had evidence
of pulmonary hypertension on electrocardiography (right ven-
tricular hypertrophy) or roentgenography (cardiomegaly or di-
lated main pulmonary arteries, or both). All these results
nearly matched with our results.
Still there are not enough researches to state that liver
transplantation is a recommended solution for PPHTN, Delc-
roix [19] stated that in the moderate-to-severe stages, liver
transplantation is not widely recommended, and is even re-
garded as a contraindication due to its negative peri- and
post-operative impact. As a consequence, screening by re-
peated transthoracic echocardiography is highly recommended
in liver transplant candidates. Therapy with prostacyclin ana-
logues may partially relieve this pulmonary hypertension.In our study we found a signiﬁcant reduction in pulmonary
artery pressure after liver transplantation with improvement in
morbidity such as dyspnea, performance, etc., however, most
of our cases were mild to moderate and our follow up period
was limited to 3 months only.
Recommendations
More studies on a larger scale and prolonged time are needed
to assess the impact of liver transplantation on PHTN and to
detect morbidity and mortality in liver transplant patients.
The use of pulmonary catheterization in assessing PHTN
and comparing its results with the echo results may become
more informative.
Also more studies are needed to compare between surgery
(liver transplantation) and medical treatment by different pul-
monary vasodilators in patients with pulmonary hypertension
associated with chronic liver disease who are not candidates
for surgery.
Limitation
The heart rate of the patients during echocardiographic exam-
ination was not identical before and after operation and this
might have affected the mean PAP measurement. PFT and
CXR were not done after operation. Also, the small number
of patients used was a limitation.
Conﬂict of interest
No conﬂict of interest in this study.
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